Skip to main content
evidena care

Costs & health insurance

Health insurer rejects cannabis: objection and other routes

The health insurer has refused cost approval for your cannabis medicine. Which routes are open afterwards, from reconsideration to objection.

Key points

  • A refusal of cost approval is often first an informal letter. No objection can yet be lodged against it, but you can request a written ruling.
  • You can lodge an objection against a ruling with the health insurer within 30 days. The objection procedure is free of charge.
  • In practice, the doctor often first submits a request for reconsideration with additional documents.
  • The health insurance ombudsman advises free of charge and mediates between you and the insurer, but does not decide in its place.
  • Cannabis medicines are not in the benefits catalogue of basic health insurance. Even legal action does not guarantee cost coverage.

If the health insurer has refused cost approval for your cannabis medicine, that is not necessarily the last word. Your doctor can submit a request for reconsideration with additional documents. You yourself can request a written ruling and lodge an objection against it within 30 days.3,6

Be realistic about this. Cannabis medicines are not in the benefits catalogue of basic health insurance, and the insurer only covers them in the individual case if the strict requirements of the Health Insurance Ordinance are met. Legal action examines whether the insurer has applied these rules correctly. It does not create an entitlement where the requirements are not met.1,4

Why the health insurer often refuses cannabis

Basic health insurance generally only pays for medicines on the list of pharmaceutical specialities. Cannabis medicines are not on it. According to the FOPH, the necessary criteria of efficacy, appropriateness and cost-effectiveness could not so far be considered met.4

Only coverage in the individual case under Art. 71a to 71d KVV is therefore possible. One of the requirements is that the medicine is expected to have a great therapeutic benefit against a disease that can be fatal or lead to severe and chronic health impairment, and that no other effective and authorised treatment is available. The insurer decides after consulting its medical adviser, within two weeks if the application is complete.1

It is precisely at this point that many applications fail. The FOPH states in its FAQ that, according to the HTA report, no great therapeutic benefit is to be expected even with the authorised ready-made medicines.4 An evaluation commissioned by the FOPH found a low approval rate for cannabis compared with other medicines. What is known about approvals is described in the hub Costs and health insurance.6

What the refusal must contain

If the insurer refuses an application, it must give reasons for the decision to the treating doctor and to you. If it relies on the assessment of the therapeutic benefit, it must enclose this assessment.1

Read the reasons together with your doctor. They show where the insurer sees a gap, for example:

  • The insurer does not consider it proven that other treatments have been exhausted.
  • It considers the expected benefit too small or not sufficiently documented.
  • It does not classify the condition as severe and chronic within the meaning of the ordinance.
  • The application was incomplete.

Which reason applies determines the sensible next step.

Step 1: Reconsideration with additional documents

The most common first step is not a legal remedy but a new, better-reasoned application. The evaluation commissioned by the FOPH describes that a request for reconsideration is often submitted after a refusal. The doctors interviewed stated that they request reconsideration for around 90 per cent of their refused applications, and that this is approved in around half of cases. These figures are based on expert interviews covering all medicines, not on statistics for cannabis.6

The request is made by your doctor. Depending on the reasons for the refusal, the following can help:

  • specialist reports on the course of the disease
  • a list of previous therapies with duration, result and reason for stopping
  • information on how the symptoms affect everyday life and ability to work
  • literature on the planned therapy for your diagnosis

Some insurers also offer a treatment trial: they only cover the costs once a benefit has been documented in the individual case. The Federal Council’s 2018 report also describes that doctors sometimes suggest paying for the first pack yourself and only then submitting an application.6,7 Whether this makes sense for you is something to discuss with your doctor.

Step 2: Health insurance ombudsman

If you have questions about the decision or doubts as to whether the insurer has acted correctly, you can contact the health insurance ombudsman (Ombudsstelle Krankenversicherung). It clears up misunderstandings between insured persons and insurers and mediates in disagreements. Advice is free of charge and can be requested by phone, web form or post.5

The ombudsman does not decide in place of the insurer. Do not count on an enquiry to it stopping the deadline for an objection. If a deadline is running, meet it.

Step 3: Request a ruling and lodge an objection

Health insurance is subject to the Federal Act on the General Part of Social Insurance Law (ATSG), unless the KVG provides otherwise.2 The formal route follows from this.

The ruling

If a person does not agree with a decision on benefits, the insurer must issue a written ruling. It must give reasons if it does not fully grant the request, and it contains information on legal remedies. If your application was refused informally, you can expressly request that a ruling be issued.3 To do so, write briefly to the insurer that you disagree with the refusal and request a contestable ruling.

The objection

You can lodge an objection against the ruling within 30 days with the insurer that issued it. The objection procedure is free of charge. As a rule, no compensation for legal costs is awarded. The insurer must give reasons for the decision on the objection and include information on legal remedies.3

The colloquial German term “Widerspruch einlegen” used in Germany corresponds to this objection (Einsprache) in Switzerland. An objection usually contains:

  1. your personal details and your insurance number
  2. the ruling you are contesting, with its date
  3. what you are requesting, for example coverage of the costs of the medicine applied for
  4. reasons, based on the medical documents
  5. date and signature

Send the objection by registered post so that you can prove the deadline was met.

After the objection: appeal to the insurance court

If the insurer rejects the objection, you can lodge an appeal with the cantonal insurance court within 30 days of notification of the decision on the objection. Each canton designates an insurance court for this. An appeal is also possible if, contrary to your request, the insurer does not issue a ruling or a decision on the objection.3

The court examines whether the requirements of Art. 71a to 71d KVV are met in the individual case.1 For this step, legal advice is worthwhile, for example through a patient organisation or legal expenses insurance.

If the insurer has also refused under a supplementary insurance policy, a different route applies: supplementary insurance is governed by private law, not by the ATSG. Your policy and the insurance terms are then decisive.

If the insurer maintains its refusal

If the refusal stands, you bear the costs of the medicine yourself or look for another solution with your doctor. For refused applications in general, the evaluation commissioned by the FOPH mentions payment by the patients themselves or alternative financing, for example through hospitals or a foundation.6

Do not stop ongoing treatment on your own because of the costs, and do not change other medicines yourself either. Decide how to proceed only in agreement with your doctor. You can see what treatment at evidena costs on the page Costs.

How it works at evidena

At evidena, the doctor decides after the consultation whether treatment with cannabis medicines is an option in your case. If a prescription is issued, it must be filled at a pharmacy within one month. As a rule, it covers the need for one month, in justified cases up to three months. Whether an application for cost approval has a chance of success is something to discuss at the appointment. We cannot promise that the insurer will cover the costs.

You can book an appointment at portal.evidena.care. We answer questions via WhatsApp or at info@evidena.care. The overall process is described under How it works.

Conclusion

A refusal of cost approval can be tackled in two ways: with a better-reasoned request for reconsideration by your doctor, and via the formal route of a ruling and an objection within 30 days. The health insurance ombudsman advises free of charge. Because cannabis medicines are only covered in the individual case, the outcome remains open even through legal action.

Frequently asked questions

Can I appeal against the health insurer's refusal?

In Switzerland, the legal remedy is called an objection (Einsprache). It is directed against a written ruling. If the insurer has only refused informally, first request a ruling.

How long do I have to lodge an objection?

30 days from notification of the ruling, according to Art. 52 ATSG. The objection goes to the health insurer that issued the ruling.

Does an objection cost anything?

No, the objection procedure is free of charge under the ATSG. As a rule, no compensation for legal costs is awarded.

What is the difference between reconsideration and objection?

In practice, a request for reconsideration is an informal new application, usually with additional medical documents. The objection is the formal legal remedy against a ruling and is subject to a deadline.

What can the health insurance ombudsman do?

It advises free of charge and mediates in disagreements with the insurer. It does not decide in place of the insurer. Do not count on an enquiry stopping the deadline for an objection.

Your situation is individual

Discuss your questions with a doctor.

Book a consultation

Sources

  1. Verordnung über die Krankenversicherung (KVV), SR 832.102, Art. 71a, 71b und 71d, Fassung vom 1. August 2026, Fedlex (accessed 13 November 2026)
  2. Bundesgesetz über die Krankenversicherung (KVG), SR 832.10, Art. 1, Fedlex (accessed 13 November 2026)
  3. Bundesgesetz über den Allgemeinen Teil des Sozialversicherungsrechts (ATSG), SR 830.1, Art. 49, 51, 52, 53, 56, 57 und 60, Fedlex (accessed 13 November 2026)
  4. FAQ Cannabisarzneimittel, Bundesamt für Gesundheit BAG, 4. März 2025 (accessed 13 November 2026)
  5. Ombudsstelle Krankenversicherung, Startseite und Beratung (accessed 13 November 2026)
  6. BSS Volkswirtschaftliche Beratung, asim. Evaluation der Vergütung von Arzneimitteln im Einzelfall nach den Art. 71a–71d KVV, Schlussbericht im Auftrag des BAG, 24. Juli 2020 (accessed 13 November 2026)
  7. Cannabis für Schwerkranke, Bericht des Bundesrates in Erfüllung der Motion Kessler 14.4164, 4. Juli 2018 (accessed 13 November 2026)

Written by evidena.care editorial team · Published 13 November 2026 · Reviewed 13 November 2026

This article is general information and does not replace medical advice. Whether cannabis therapy is an option for you is decided by a doctor in a personal consultation.